Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FLORTAUCIPIR F-18
- Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease
- SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease
- Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects
- Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease
- Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study
- Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease
- A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation
- Tau Screening Study in Subjects With Early Symptomatic AD
- Tau Screening Study in Patients With Early Symptomatic AD
- Flortaucipir 18F PET Imaging in BIOCARD Study
- Flortaucipir PET Imaging in Subjects With FTD
- Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05
- 18F-AV-1451 Autopsy Study
- Augmenting Flortaucipir Dosimetry Estimates
- Clinical Evaluation of Flortaucipir F 18
- Tau Imaging in Professional Fighters
- Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
- 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
- Imaging Characteristics of a Follow-up 18F-AV-1451 Scan
- Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects
- A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects
Clinical trials list
click for details